Nathaniel Melling
Impact in
- Oncology top 10%
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Jakob R. Izbicki (53 shared papers)Ronald Simon (22 shared papers)Guido Sauter (22 shared papers)Matthias Reeh (28 shared papers)Luigi Terracciano (7 shared papers)Andreas H. Marx (7 shared papers)Carsten Bokemeyer (7 shared papers)Martina Kluth (13 shared papers)
- Journals
- Scientific Reports (7 papers)Cancers (6 papers)Journal of Cancer Research and Clinical Oncology (5 papers)PLoS ONE (5 papers)Experimental and Molecular Pathology (4 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Nathaniel Melling
66 papers receiving 927 citations
Peers
Comparison fields: 5 of 100
- Oncology 309
- Cancer Research 147
- Pulmonary and Respiratory Medicine 158
- Molecular Biology 273
- Surgery 159
Countries citing papers authored by Nathaniel Melling
This map shows the geographic impact of Nathaniel Melling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel Melling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel Melling more than expected).
Fields of papers citing papers by Nathaniel Melling
This network shows the impact of papers produced by Nathaniel Melling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel Melling. The network helps show where Nathaniel Melling may publish in the future.
Co-authors
The 25 scholars most cited alongside Nathaniel Melling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 110 | |
| 2 | 2017 | 42 | |
| 3 | 2016 | 40 | |
| 4 | 2015 | 40 | |
| 5 | 2015 | 35 | |
| 6 | 2015 | 33 | |
| 7 | 2017 | 33 | |
| 8 | High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer. | 2015 | 30 |
| 9 | 2021 | 28 | |
| 10 | 2015 | 28 | |
| 11 | 2018 | 27 | |
| 12 | 2015 | 26 | |
| 13 | 2019 | 25 | |
| 14 | 2021 | 24 | |
| 15 | 2022 | 21 | |
| 16 | 2015 | 21 | |
| 17 | 2015 | 21 | |
| 18 | 2015 | 20 | |
| 19 | 2015 | 20 | |
| 20 | 2009 | 18 |
About Nathaniel Melling
Nathaniel Melling is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 71 papers that have together received 944 indexed citations. Recurring topics across this work include Esophageal and GI Pathology (7 papers), Esophageal Cancer Research and Treatment (7 papers), Prostate Cancer Treatment and Research (6 papers), Glycosylation and Glycoproteins Research (5 papers), Cancer Cells and Metastasis (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Genetic factors in colorectal cancer (5 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Oncology (309 citations), Cancer Research (147 citations), Pulmonary and Respiratory Medicine (158 citations), Molecular Biology (273 citations) and Surgery (159 citations). Nathaniel Melling has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Jakob R. Izbicki, Ronald Simon, Guido Sauter, Matthias Reeh, Luigi Terracciano, Andreas H. Marx, Carsten Bokemeyer, Martina Kluth, Claudia Hube‐Magg and Waldemar Wilczak. Their work appears in journals such as Scientific Reports, Cancers, Journal of Cancer Research and Clinical Oncology, PLoS ONE and Experimental and Molecular Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.